Evaluating Appropriate Use Of Blood Products In Mothers And Babies
Funder
National Health and Medical Research Council
Funding Amount
$392,137.00
Summary
There has been an increase in blood transfusions following childbirth. Blood transfusions are potentially life-saving treatments for mothers and babies facing life-threatening illnesses or complications involving haemorrhage, however there is potential to be over-transfusing mothers and babies who are exposed to unnecessary risk of adverse outcomes such as infection. We aim to evaluate and improve the safety and appropriate use of blood and blood products during pregnancy, childbirth and the new ....There has been an increase in blood transfusions following childbirth. Blood transfusions are potentially life-saving treatments for mothers and babies facing life-threatening illnesses or complications involving haemorrhage, however there is potential to be over-transfusing mothers and babies who are exposed to unnecessary risk of adverse outcomes such as infection. We aim to evaluate and improve the safety and appropriate use of blood and blood products during pregnancy, childbirth and the newborn period.Read moreRead less
Exploring The Impact Of Blood Transfusion On Maternity Outcomes And Healthcare Utilisation: Informing The Use Of Blood And Blood Products In The Obstetric Setting
Funder
National Health and Medical Research Council
Funding Amount
$492,479.00
Summary
Around 1 in 10 women suffer excessive bleeding after childbirth, 15% of whom will have a blood transfusion. New guidelines for obstetric blood management will be released in 2015. This research will investigate obstetric transfusion practices before and after guideline implementation. Research aims include identifying variation in treatment of women at risk of and experiencing transfusion, addressing knowledge gaps in guidelines and investigating emerging issues in obstetric transfusion medicine
Improving Outcomes For Patients With Critical Bleeding Requiring Massive Transfusion
Funder
National Health and Medical Research Council
Funding Amount
$877,786.00
Summary
Blood transfusions— the most common procedure in Australian hospitals —are life-saving for people with uncontrolled bleeding. They cost Australia more than $1 billion each year and despite their life-saving potential their risks are concerning. This project, led by ANZ researchers, health professionals, blood service stakeholders and government representatives, will provide new information about how to improve the safety and outcomes of patients receiving blood transfusions in our hospitals.